Bezitramide: Withdrawn from Dutch market in 2004 following pediatric fatality. Extremely delayed onset encourages dangerous redosing before peak effects manifest. Historical 5 mg tablets represented supratherapeutic doses for opioid-naive users. Prodrug rapidly hydrolyzed to active metabolite despro
Related pages